{"eventGroups":[{"description":"Bone marrow stem cell transplant program to improve the outcome of allogeneic Bone Marrow Transplant for hematologic malignancies. Immunosuppression including cyclosporine will be given six days prior to transplant up to 21 days post transplant. CD34 selection and T cell depletion using Isolex 300i immuno-magnetic cell selection and immunosuppression during peri- transplant.","id":"EG000","otherNumAffected":49,"otherNumAtRisk":49,"seriousNumAffected":25,"seriousNumAtRisk":49,"title":"Bone Marrow Transplantation Using Nexell Isolex 300i"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":49,"numEvents":10}],"term":"Acute GVHD before day 60"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":22,"numAtRisk":49,"numEvents":22}],"term":"Chronic GVHD"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":49,"numEvents":4}],"term":"Hemorrhagic cystitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","stats":[{"groupId":"EG000","numAffected":37,"numAtRisk":49,"numEvents":37}],"term":"Cytomegalovirus disease"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":49,"numEvents":18}],"term":"Disease Relapse"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":49,"numEvents":19}],"term":"Acute GVHD after day 60"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":49,"numEvents":9}],"term":"Transplant Related Death"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":49,"numEvents":1}],"term":"Hospitalization"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":49,"numEvents":2}],"term":"Hospitalization"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":49,"numEvents":12}],"term":"Death"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":49,"numEvents":1}],"term":"Life threatening"}],"timeFrame":"Overall study"}